These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7083128)

  • 21. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.
    Reddy SG; Kiel KD
    Breast J; 2007; 13(1):12-8. PubMed ID: 17214788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
    Donker M; van Tienhoven G; Straver ME; Meijnen P; van de Velde CJ; Mansel RE; Cataliotti L; Westenberg AH; Klinkenbijl JH; Orzalesi L; Bouma WH; van der Mijle HC; Nieuwenhuijzen GA; Veltkamp SC; Slaets L; Duez NJ; de Graaf PW; van Dalen T; Marinelli A; Rijna H; Snoj M; Bundred NJ; Merkus JW; Belkacemi Y; Petignat P; Schinagl DA; Coens C; Messina CG; Bogaerts J; Rutgers EJ
    Lancet Oncol; 2014 Nov; 15(12):1303-10. PubMed ID: 25439688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
    Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
    Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
    Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
    Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
    Gruber G; Berclaz G; Altermatt HJ; Greiner RH
    Strahlenther Onkol; 2003 Oct; 179(10):661-6. PubMed ID: 14566473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
    Aksu G; Kucucuk S; Fayda M; Saynak M; Baskaya S; Saip P; Ozturk N; Aslay I
    Eur J Surg Oncol; 2007 Apr; 33(3):285-93. PubMed ID: 17145158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution.
    Yang Y; He Y; Fan Z; Ouyang T
    Breast; 2017 Dec; 36():20-24. PubMed ID: 28869832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
    Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
    J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
    Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
    Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
    Bonadonna G; Rossi A; Valagussa P; Banfi A; Veronesi U
    Cancer; 1977 Jun; 39(6 Suppl):2904-15. PubMed ID: 326384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis].
    Liao YQ; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):615-8. PubMed ID: 18210884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation therapy in operable breast cancer: results from the Stockholm trial on adjuvant radiotherapy.
    Wallgren A; Arner O; Bergström J; Blomstedt B; Granberg PO; Räf L; Silfverswärd C; Einhorn J
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):533-7. PubMed ID: 3516951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.